Brochure Coming Soon
The Clinical Trials Coordination Center (CTCC) operates to foster multi-institutional
academic research through the development, management, and reporting of hypothesis-driven,
controlled clinical trials.
Under the direction of a dedicated staff of physicians and healthcare professionals
specializing in movement disorders, the CTCC has been in operation since 1986, initially
to support the National Institute of Health (NIH) sponsored DATATOP (Deprenyl and
Tocopherol Antioxidative Therapy of Parkinsonism) trial. The CTCC has since grown
to support a full array of services essential to clinical trials services for industry,
foundations, and government sponsors. The CTCC works in close collaboration with the Department of Biostatistics and Computational
Biology at the University of Rochester to provide a complete suite of clinical trials services.
The CTCC is utilized by several multi-center investigator-initiated consortia including
the Parkinson Study Group (PSG),
the Huntington Study Group (HSG),
the NIH Exploratory Trials in Parkinson's Disease (NET-PD),
and the Neuro-Ophthamlmology Research Disease Investigator Consortium (NORDIC) Network. These study groups are comprised of
more than 350 academic investigators from the United States, Canada, Europe and
Australia. The CTCC is also one of the primary research training sites for a National Institute
of Health funded training grant: Experimental Therapeutics in Neurological Disease,
R.C. Griggs, PI (Clinical Neuroscience, #NS-07338).